(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.38%) $966.30
(-0.36%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.36%) $91.45
2.07% $ 3.45
Live Chart Being Loaded With Signals
AzurRx BioPharma, Inc. engages in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal disorders...
Stats | |
---|---|
Volumen de hoy | 629 030 |
Volumen promedio | 713 030 |
Capitalización de mercado | 3.43M |
EPS | $-1.600 ( 2021-08-16 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.845 |
ATR14 | $0.0530 (1.54%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2021-09-09 | Coelho Mary Theresa | Buy | 10 310 | Stock option (right to buy) |
2021-08-11 | Coelho Mary Theresa | Buy | 0 | |
2021-07-09 | Pennington James | Buy | 100 000 | Stock option (right to buy) |
2021-06-30 | Schneiderman Daniel H | Buy | 250 000 | Stock option (right to buy) |
2021-06-30 | Schneiderman Daniel H | Buy | 35 006 | Stock option (right to buy) |
INSIDER POWER |
---|
0.00 |
Last 81 transactions |
Buy: 5 836 949 | Sell: 2 173 162 |
Volumen Correlación
AzurRx BioPharma Inc Correlación
10 Correlaciones Más Positivas | |
---|---|
GAINL | 0.969 |
HILS | 0.956 |
MBIN | 0.948 |
ALR | 0.948 |
PSTX | 0.929 |
RELI | 0.925 |
TYRA | 0.924 |
LFMDP | 0.922 |
PCSA | 0.921 |
SATL | 0.921 |
10 Correlaciones Más Negativas | |
---|---|
BOCH | -0.962 |
SHSP | -0.934 |
TBIO | -0.928 |
CCSI | -0.927 |
EYE | -0.925 |
MMAC | -0.921 |
ACHC | -0.909 |
PPYAU | -0.908 |
SY | -0.902 |
SILK | -0.898 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
AzurRx BioPharma Inc Correlación - Moneda/Commodity
AzurRx BioPharma Inc Finanzas
Annual | 2020 |
Ingresos: | $0.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-5 902 903 |
FY | 2020 |
Ingresos: | $0.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-5 902 903 |
FY | 2019 |
Ingresos: | $0.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-6.77 |
FY | 2018 |
Ingresos: | $0.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-8.77 |
Financial Reports:
No articles found.
AzurRx BioPharma Inc
AzurRx BioPharma, Inc. engages in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal disorders. The company is headquartered in Brooklyn, New York and currently employs 12 full-time employees. The firm is engaged in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal (GI) disorders. The firm's product pipeline consists of two therapeutic proteins, such as MS1819 and AZX1101. MS1819 is an acid-resistant secreted lipase produced by Yarrowia lipolytica, known as LIP2, that the Company is developing through recombinant deoxyribonucleic acid (DNA) technology for the treatment of exocrine pancreatic insufficiency (EPI), associated with chronic pancreatitis (CP) and cystic fibrosis (CF). AZX1101 is a recombinant-lactamase combination of bacterial origin under development for the prevention of hospital-acquired infections by resistant bacterial strains induced by parenteral administration of b-lactam antibiotics (known as nosocomial infections), as well as the prevention of antibiotic-associated diarrhea (AAD).
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico